$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
Sector
Health Technology
CEO
Todd Franklin Watanabe
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Website
Top Stories
Coming soon.